参考文献/References:
[1] 中国医师协会急诊医师分会,国家卫健委能力建设与继续教育中心急诊学专家委员会,中国医疗保健国际交流促进会急诊急救分会,等. 急性冠脉综合征急诊快速诊治指南(2019)[J]. 中华急诊医学杂志,2019,39(4):421-428.
[2] 高晓津,杨进刚,吴超,等. TIMI风险评分与GRACE风险评分对中国ST段抬高型心肌梗死患者院内死亡率的预测价值[J]. 中国循环杂志,2018,33(6):529-534.
[3] 吴超,高晓津,赵延延,等. TIMI评分与GRACE评分对中国急性非ST段抬高型心肌梗死患者院内死亡率的预测价值[J]. 中华心血管病杂志,2019,47(4):297-304.
[4] Granger CB,Goldberg RJ,Dabbous O,et al. Predictors of hospital mortality in the global registry of acute coronary events[J]. Arch Intern Med,2003,163(19):2345-2353.
[5] Eagle KA,Lim MJ,Dabbous OH,et al. A validated prediction model for all forms of acute coronary syndrome:estimating the risk of 6-month postdischarge death in an international registry[J]. JAMA,2004,291(22):2727-2733.
[6] Stark K,Massberg S. Interplay between inflammation and thrombosis in cardiovascular pathology[J]. Nat Rev Cardiol,2021,18(9):666-682.
[7] Danesh J,Wheeler JG,Hirschfield GM,et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease[J]. N Engl Med,2004,350(14):1387-1397.
[8] Yang X,Zhang D,Zhao Y,et al. Association between serum level of C-reactive protein and risk of cardiovascular events based on cohort studies[J]. J Hum Hypertens,2021,35(12):1149-1158.
[9] He LP,Tang XY,Ling WH,et al. Early C-reactive protein in the prediction of long-term outcomes after acute coronary syndromes:a meta-analysis of longitudinal studies[J]. Heart,2010,96(5):339-346.
[10] Lin XL,Sun HX,Li FQ,et al. Admission high-sensitivity C-reactive protein levels improve the Grace risk score prediction on in-hospital outcomes in acute myocardial infarction patients[J]. Clin Cardiol,2022,45(3):282-290.
[11] Soehnlein O. Multiple roles for neutrophils in atherosclerosis[J]. Circ Res,2012,110(6):875-888.
[12] Zhang N,Aiyasiding X,Li WJ,et al. Neutrophil degranulation and myocardial infarction[J]. Cell Commun Signal,2022,20(1):50.
[13] Chia S,Nagurney JT,Brown DF,et al. Association of leukocyte and neutrophil counts with infarct size,left ventricular function and outcomes after percutaneous coronary intervention for ST-elevation myocardial infarction[J]. Am J C ardiol,2009,103(3):333-337.
[14] Zhang S,Wan Z,Zhang Y,et al. Neutrophil count improves the GRACE risk score prediction of clinical outcomes in patients with ST-elevation myocardial infarction[J]. Atherosclerosis,2015,241(2):723-728.
[15] Agarwal R,Aurora RG,Siswanto BB,et al. The prognostic value of neutrophil-to-lymphocyte ratio across all stages of coronary artery disease[J]. Coron Artery Dis,2022,33(2):137-143.
[16] Dentali F,Nigro O,Squizzato A,et al. Impact of neutrophils to lymphocytes ratio on major clinical outcomes in patients with acute coronary syndromes:a systematic review and meta-analysis of the literature[J]. Int J Cardiol,2018,266:31-37.
[17] Zhou D,Wan Z,Fan Y,et al. A combination of the neutrophil-to-lymphocyte ratio and the GRACE risk score better predicts PCI outcomes in Chinese Han patients with acute coronary syndrome[J]. Anatol J Cardiol,2015,15(12):995-1001.
[18] Weitz JI,Fredenburgh JC,Eikelboom JW. A test in context:D-dimer[J]. J Am coll Cardio,2017,70(19):2411-2420.
[19] Kothari H,Nguyen AT,Yang X,et al. Association of D-dimer with plaque characteristics and plasma biomarkers of oxidation-specific epitopes in stable subjects with coronary artery disease[J]. J Cardiovasc Transl Res,2018,11(3):221-229.
[20] Gong X,Lei X,Huang Z,et al. D-dimer level predicts angiographic no-reflow phenomenon after percutaneous coronary intervention within 2-7?days of symptom onset in patients with ST-segment elevation myocardial infarction[J]. J Cardiovasc Transl Res,2021,14(4):728-734.
[21] Zhang X,Wang S,Liu J,et al. D-dimer and the incidence of heart failure and mortality after acute myocardial infarction[J]. Heart,2021,107(3):237-244.
[22] Yu T,Jiao Y,Song J,et al. Hospital mortality in acute coronary syndrome:adjustment of GRACE score by D-dimer enables a more accurate prediction in a prospective cohort study[J]. BMC Cardiovasc Disord,2019,19(1):252.
[23] Spahn DR,Bouillon B,Cerny V,et al. The European guideline on management of major bleeding and coagulopathy following trauma:fifth edition[J]. Crit Care,2019,23(1):98.
[24] 贾媛芳,张雪娟,郭俊杰. 血栓弹力图在心血管疾病诊治中的应用进展[J]. 心血管病学进展,2015,36(2):207-210.
[25] Zhou Q,Mao M,Meng J,et al. The thromboelastography G parameter as a potential biomarker of acute coronary syndrome[J]. Scand J Cli Lab Invest,2020,80(3):196-201.
[26] 王凯阳,闵轩,宁怡,等. GRACE评分联合血栓弹力图对急性冠脉综合征患者主要心血管不良事件的早期预测价值[J]. 石河子大学学报(自然科学版),2022,40(3):383-389.
[27] Simon T,Verstuyft C,Mary-Krause M,et al. Genetic determinants of response to clopidogrel and cardiovascular events[J]. N Engl J Med,2009,360(4):363-375.
[28] Bai XF,Zhang YP,Zhou J,et al. Combination of the CYP2C19 metabolizer and the GRACE risk score better predicts the long-term major adverse cardiac events in acute coronary syndrome undergoing percutaneous coronary intervention[J]. Thromb Res,2018,170:142-147.
[29] de Lemos JA,McGuire DK,Drazner MH. B-type natriuretic peptide in cardiovascular disease[J]. Lancet,2003,362(9380):316-322.
[30] McDonagh TA,Metra M,Adamo M,et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure[J]. Eur Heart J,2021,42(36):3599-3726.
[31] Emdin M,Passino C,Prontera C,et al. Comparison of brain natriuretic peptide (BNP) and amino-terminal proBNP for early diagnosis of heart failure[J]. Clin Chem,2007,53(7):1289-1297.
[32] Gong X,Zhang T,Feng S,et al. Association between N-terminal pro-BNP and 12 months major adverse cardiac events among patients admitted with NSTEMI[J]. Ann Palliat Med,2021,10(5):5231-5243.
[33] Jabbar A,Pingitore A,Pearce SH,et al. Thyroid hormones and cardiovascular disease[J]. Nat Rev Cardiol,2017,14(1):39-55.
[34] Chang X,Zhang S,Zhang M,et al. Free triiodothyronine and global registry of acute coronary events risk score on predicting long-term major adverse cardiac events in STEMI patients undergoing primary PCI[J]. Lipids Health Dis,2018,17(1):234.
[35] Yu T,Tian C,Song J,et al. Value of the fT3/fT4 ratio and its combination with the GRACE risk score in predicting the prognosis in euthyroid patients with acute myocardial infarction undergoing percutaneous coronary intervention: a prospective cohort study[J]. BMC Cardiovasc Disord,2018,18(1):181.
[36] Chattopadhyay S,George A,John J,et al. Two-hour post-load plasma glucose,a biomarker to improve the GRACE score in patients without known diabetes[J]. Cardiology,2020,145(9):553-561.
[37] Liu XJ,Wan ZF,Zhao N,et al. Adjustment of the GRACE score by HemoglobinA1c enables a more accurate prediction of long-term major adverse cardiac events in acute coronary syndrome without diabetes undergoing percutaneous coronary intervention[J]. Cardiovasc Diabetol,2015,14(null):110.
[38] Luo J,Xu S,Li H,et al. Prognostic impact of stress hyperglycemia ratio in acute myocardial infarction patients with and without diabetes mellitus[J]. Nutr Metab Cardiovasc Dis,2022,32(10):2356-2366.
[39] Xiong S,Chen Q,Chen X,et al. Adjustment of the GRACE score by the triglyceride glucose index improves the prediction of clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention[J]. Cardiovasc Diabetol,2022,21(1):145.
[40] Raposeiras Roubín S,Abu Assi E,Cespón Fernandez M,et al. Prevalence and prognostic significance?of malnutrition in patients with acute?coronary syndrome[J]. J Am Coll C ardiol,2020,76(7):828-840.
相似文献/References:
[1]李润土,何泉.光学相干断层成像在急性冠脉综合征介入治疗中的应用[J].心血管病学进展,2019,(6):856.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.005]
LI Runtu,HE Quan.Application of Optical Coherent Tomography in Interventional Treatment of Acute Coronary Syndrome[J].Advances in Cardiovascular Diseases,2019,(6):856.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.005]
[2]郑晓雪 季福绥.急性冠脉综合征患者发生急性肾损伤的临床进展[J].心血管病学进展,2019,(5):713.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.013]
ZHENG Xiaoxue,JI Fusui.Acute Kidney Injury in Patients with Acute Coronary Syndrome[J].Advances in Cardiovascular Diseases,2019,(6):713.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.013]
[3]周小琳 何泉.替格瑞洛在急性冠脉综合征合并慢性肾脏病患者中的应用研究进展[J].心血管病学进展,2019,(5):718.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.014]
ZHOU Xiaolin,HE Quan.Ticagrelor in Acute Coronary Syndrome with Chronic Kidney Disease[J].Advances in Cardiovascular Diseases,2019,(6):718.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.014]
[4]吕俊兴 许海燕.急性冠脉综合征危险评分的研究进展[J].心血管病学进展,2019,(9):1224.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.010]
LU Junxing,XU Haiyan.Risk Scores of Acute Coronary Syndrome[J].Advances in Cardiovascular Diseases,2019,(6):1224.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.010]
[5]吕颖 胡思宁 于波 贾海波.斑块侵蚀发病机制的最新研究进展[J].心血管病学进展,2020,(1):74.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.020]
LU Ying,HU Sining,YU Bo,et al.Pathogenic Mechanisms of Plaque Erosion[J].Advances in Cardiovascular Diseases,2020,(6):74.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.020]
[6]段继坤,林志,杨帆,等.斑块侵蚀引起的急性冠脉综合征的研究新进展[J].心血管病学进展,2020,(3):281.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.016]
DUAN Jikun,LIN Zhi,YANG Fan,et al.Acute Coronary Syndrome Caused by Plaque Erosion[J].Advances in Cardiovascular Diseases,2020,(6):281.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.016]
[7]陈凯磊 胡闻竹 苏冠华.P2Y12抑制剂与癌症风险的相关性研究进展[J].心血管病学进展,2020,(8):798.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.004]
CHEN Kailei,HU Wenzhu,SU Guanhua.Advances in Studies on the Correlation between P2Y12 Inhibitors and Cancer Risk[J].Advances in Cardiovascular Diseases,2020,(6):798.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.004]
[8]肖雨尘 赵仙先 马丽萍.急性冠脉综合征患者提前停服替格瑞洛现象的研究进展[J].心血管病学进展,2020,(11):1120.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
Acute Coronary Syndrome.Premature Ticagrelor Discontinuation in Patients with[J].Advances in Cardiovascular Diseases,2020,(6):1120.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
[9]冯洁渊 .中性粒细胞/淋巴细胞比值和血小板/淋巴细胞比值与急性冠脉综合征的关系研究进展[J].心血管病学进展,2020,(12):1276.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.013]
FENG Jieyuan.The Relationship Between Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio and Acute Coronary Syndrome[J].Advances in Cardiovascular Diseases,2020,(6):1276.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.013]
[10]魏倩 梁岩.高敏心肌肌钙蛋白在急性冠脉综合征患者中的临床应用进展[J].心血管病学进展,2021,(5):396.[doi:10.16806/j.cnki.issn.1004-3934.2021.05.003]